Endo Pharma LLC Sample Contracts

EXHIBIT 6 AMENDED AND RESTATED STOCKHOLDERS AGREEMENT ENDO PHARMACEUTICALS HOLDINGS INC. Dated as of July 14, 2000 TABLE OF CONTENTS
Stockholders Agreement • July 27th, 2000 • Endo Pharma LLC • Pharmaceutical preparations • Delaware
AutoNDA by SimpleDocs
EXHIBIT 5 LIMITED LIABILITY COMPANY AGREEMENT
Limited Liability Company Agreement • July 27th, 2000 • Endo Pharma LLC • Pharmaceutical preparations • Delaware
as Warrant Agent
Warrant Agreement • July 27th, 2000 • Endo Pharma LLC • Pharmaceutical preparations • New York
EXCHANGE AGREEMENT
Exchange Agreement • July 27th, 2000 • Endo Pharma LLC • Pharmaceutical preparations • Delaware
EXHIBIT 14 REGISTRATION RIGHTS AGREEMENT by and between ENDO PHARMACEUTICALS HOLDINGS INC.
Registration Rights Agreement • July 27th, 2000 • Endo Pharma LLC • Pharmaceutical preparations • Delaware
Pre-Merger Endo Warrant ----------------------- THE SECURITIES REPRESENTED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE "SECURITIES ACT") OR THE APPLICABLE STATE SECURITIES OR "BLUE SKY" LAWS (SUCH FEDERAL AND STATE...
Warrant Agreement • July 27th, 2000 • Endo Pharma LLC • Pharmaceutical preparations • New York

This Warrant Certificate certifies that Endo Pharma LLC, or registered assigns, is the registered holder of Warrants expiring on or before July 7, 2003 (the "Warrants") to purchase shares of Common Stock, par value $.01 per share (the "Common Stock"), of Endo Pharmaceuticals Holdings Inc., a Delaware corporation (the "Company"). Each Warrant entitles the holder upon exercise to receive from the Company on or after the Exercisability Date and on or before 5:00 p.m. New York City Time on July 7, 2003 (the six-month anniversary of the Exercisability Date), (a) 0.416667 fully paid and nonassessable shares of Common Stock (each such share, a "Warrant Share") in the event the Adjustment Event (as defined in that certain Agreement and Plan of Merger, dated as of November 26, 1999, as may be amended and restated from time to time, by and among the Company, Endo Inc., a Delaware corporation and wholly owned subsidiary of the Company, and Algos Pharmaceutical Corporation, a Delaware corporation)

November 26, 1999 Algos Pharmaceutical Corporation 1333 Campus Parkway Neptune, New Jersey 07753 Dear Sirs: In connection with that Agreement and Plan of Merger (the "Merger Agreement"), dated of even date herewith, by and among Endo Pharmaceuticals...
Merger Agreement • July 27th, 2000 • Endo Pharma LLC • Pharmaceutical preparations

In connection with that Agreement and Plan of Merger (the "Merger Agreement"), dated of even date herewith, by and among Endo Pharmaceuticals Holdings Inc. ("Holdings"), Endo Inc. and [Target] Pharmaceutical Corporation, each of the undersigned (collectively, the "Executives") hereby agrees to consent to (a) the termination of the Holdings' 1997 Executive Stock Option Plan, (b) the institution of a stock option plan of a newly formed limited liability company (the "LLC") pursuant to which each of the Executive's stock options will be exercisable only into shares of common stock of Holdings that is owned by the LLC, (c) the conversion of each of the Executive's outstanding options under Holdings' 1997 Executive Stock Option Plan into options under the stock option plan of the LLC and (d) the terms (including, but not limited to, the vesting schedule thereto) of such converted options under the stock option plan of the LLC are to be agreed upon by the Executives and the LLC. Each of the

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!